Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Nanopore Technologies Regulatory News (ONT)

Share Price Information for Oxford Nanopore Technologies (ONT)

Share Price is delayed by 15 minutes
Get Live Data
130.90    0.60 (0.46%)
Bid:
130.90
Ask:
133.00
Spread: 2.10 (1.604%)
Market Cap: £1.27b
ONT Live PriceLast checked at - London Stock Exchange

Intraday Oxford Nanopore Technologies Share Chart

Director/PDMR Shareholding

12 Apr 2022 13:01

RNS Number : 1479I
Oxford Nanopore Technologies plc
12 April 2022
 

12 April 2022

Oxford Nanopore Technologies plc (the "Company")

Director/PDMR Notification

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

The Company announces that on 11 April 2022, it made conditional awards over ordinary shares of £0.0001 each under the Oxford Nanopore Technologies plc Annual Long-Term Incentive Plan 2021 ("Annual LTIP")[1], to those Persons Discharging Managerial Responsibilities (each a "PDMR") outlined below.

Name

Number of shares subject to award granted under Annual LTIP

Gordon Sanghera (Director)

523,560

Clive Brown (Director)

314,136

Timothy Cowper (Director)

261,780

Spike Willcocks (Director)

329,991

 

The Annual LTIP awards are subject to the achievement of performance conditions over a three-year period and a subsequent two-year holding period. These awards are subject to stretching TSR performance conditions with 25% vesting at median rising to full vesting at upper quartile. TSR is measured, as to 50%, relative to a bespoke group of 18 international life sciences companies and, as to the other 50%, relative to the constituents of the FTSE350 (ignoring investment trusts). The Annual LTIP awards will accrue a dividend equivalent between the award date and the end of the holding period.

The number of shares over which the awards were granted was calculated based on a price of £3.82 per share. This is the average closing middle-market share price, as derived from the Daily Official List of the London Stock Exchange, for the five business days preceding the award date.

This announcement is made pursuant to the Company's obligations under Article 19 of the UK Market Abuse Regulation.

Gordon Sanghera - LTIP award granted

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Gurdial (Gordon) Sanghera

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial/Amendment notification

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oxford Nanopore Technologies plc

b)

LEI

213800IRWQ2Q6M2CDW55

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 Ordinary shares of £0.0001 each

 

 

GB00BP6S8Z30

b)

Nature of the transaction

Award granted for nil consideration under the Long-Term Incentive Plan 2021 due to vest in 2025 subject to the achievement of performance conditions

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

523,560

 

d)

Aggregated information

- Aggregated volume

- Aggregated price

 

523,560

Nil

e)

Date of the transaction

11 April 2022

f)

Place of the transaction

London Stock Exchange (XLON)

 

Clive Brown - LTIP award granted

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Clive Brown

2

Reason for the notification

a)

Position/status

Chief Technology Officer

b)

Initial/Amendment notification

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oxford Nanopore Technologies plc

b)

LEI

213800IRWQ2Q6M2CDW55

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 Ordinary shares of £0.0001 each

 

 

GB00BP6S8Z30

b)

Nature of the transaction

Award granted for nil consideration under the Long-Term Incentive Plan 2021 due to vest in 2025 subject to the achievement of performance conditions

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

314,136

 

d)

Aggregated information

- Aggregated volume

- Aggregated price

 

314,136

£Nil

e)

Date of the transaction

11 April 2022

f)

Place of the transaction

London Stock Exchange (XLON)

 

Timothy Cowper - LTIP award granted

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Timothy Cowper

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial/Amendment notification

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oxford Nanopore Technologies plc

b)

LEI

213800IRWQ2Q6M2CDW55

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 Ordinary shares of £0.0001 each

 

 

GB00BP6S8Z30

b)

Nature of the transaction

Award granted for nil consideration under the Long-Term Incentive Plan 2021 due to vest in 2025 subject to the achievement of performance conditions

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

261,780

 

d)

Aggregated information

- Aggregated volume

- Aggregated price

 

261,780

£Nil

e)

Date of the transaction

11 April 2022

f)

Place of the transaction

London Stock Exchange (XLON)

 

Spike Willcocks - LTIP award granted

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

James (Spike) Willcocks

2

Reason for the notification

a)

Position/status

Chief Strategy Officer

b)

Initial/Amendment notification

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oxford Nanopore Technologies plc

b)

LEI

213800IRWQ2Q6M2CDW55

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 Ordinary shares of £0.0001 each

 

 

GB00BP6S8Z30

b)

Nature of the transaction

Award granted for nil consideration under the Long-Term Incentive Plan 2021 due to vest in 2025 subject to the achievement of performance conditions

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£Nil

329,991

 

d)

Aggregated information

- Aggregated volume

- Aggregated price

 

329,991

£Nil

e)

Date of the transaction

11 April 2022

f)

Place of the transaction

London Stock Exchange (XLON)

 

[ENDS]

Enquiries:

Investors

ir@nanoporetech.com 

Media 

media@nanoporetech.com

oxfordnanoporetechnologies@tulchangroup.com

 

 

[1] This is distinct to the Conditional Retention Equity Awards issued prior to the IPO.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBBGDSSSBDGDD
Date   Source Headline
4th Jun 20262:30 pmRNSResult of AGM
1st Jun 20264:00 pmRNSIssue of Equity and Total Voting Rights
21st May 20267:01 amRNSLondon Calling Technology Update
21st May 20267:00 amRNSOxford Nanopore strengthens executive team
13th May 20263:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
12th May 20267:00 amRNSDirector/PDMR Shareholding
1st May 20263:00 pmRNSIssue of Equity and Total Voting Rights
1st May 20267:00 amRNSPublication of Annual Report and Notice of AGM
15th Apr 20265:30 pmRNSDirector/PDMR Shareholding - LTIP and DBP awards
14th Apr 20264:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
13th Apr 20263:00 pmRNSDirector/PDMR Shareholding - LTIP and DBP awards
1st Apr 20263:00 pmRNSIssue of Equity and Total Voting Rights
26th Mar 20263:00 pmRNSBlock Admission Application
4th Mar 20267:00 amRNS-RUpcoming Investor Events and Conferences
3rd Mar 20264:00 pmRNSGrant of LTIP awards; Director/PDMR Notification
3rd Mar 20267:00 amRNSDirector/PDMR Shareholding
2nd Mar 20264:00 pmRNSIssue of Equity and Total Voting Rights
2nd Mar 20267:00 amRNSAnnual results for the year ended 31 December 2025
27th Feb 20263:00 pmRNSUpdate on legal action against MGI Australia
27th Feb 20261:30 pmRNSDirector Declaration - John O'Higgins
12th Feb 20264:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
2nd Feb 20263:00 pmRNSIssue of Equity and Total Voting Rights
14th Jan 20264:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
12th Jan 20267:00 amRNSFull Year Trading Update and Notice of Results
7th Jan 20267:00 amRNS-RUpcoming Investor Events and Conferences
2nd Jan 20263:00 pmRNSIssue of Equity and Total Voting Rights
12th Dec 20253:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
8th Dec 20259:00 amRNSAGM Post-Meeting Shareholder Engagement Update
8th Dec 20257:00 amRNSAppointment of Francis Van Parys as CEO
1st Dec 20254:00 pmRNSIssue of Equity and Total Voting Rights
27th Nov 20257:00 amRNS-RUpcoming investor conferences
12th Nov 20254:30 pmRNSShare Incentive Plan - Director/PDMR Shareholding
7th Nov 20259:00 amRNSONT postpones investor event; reaffirms guidance
3rd Nov 20253:00 pmRNSIssue of Equity and Total Voting Rights
16th Oct 20257:00 amRNS-RUpcoming Investor Conferences and Events
14th Oct 20254:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
6th Oct 20255:30 pmRNSBlock listing Interim Review
1st Oct 20254:00 pmRNSIssue of Equity and Total Voting Rights
12th Sep 20254:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
2nd Sep 20257:00 amRNSInterim results for the 6 months ended 30 June 25
1st Sep 20255:00 pmRNSIssue of Equity and Total Voting Rights
13th Aug 20254:00 pmRNSShare Incentive Plan - Director/PDMR Notification
11th Aug 20257:00 amRNSChief Executive Officer Succession
8th Aug 20257:00 amRNSResult of Audit Tender
6th Aug 20257:00 amRNSCommencement of legal action against MGI Australia
1st Aug 20254:30 pmRNSIssue of Equity and Total Voting Rights
29th Jul 20257:00 amRNSHolding(s) in Company
21st Jul 20257:00 amRNSHalf Year Trading Update and Notice of Results
14th Jul 20256:00 pmRNSShare Incentive Plan - Director/PDMR Notification
4th Jul 20254:30 pmRNS-RPublication of 2024 Sustainability Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.